CY1113377T1 - Τετραϋποκατεστημενοι πυριδαζινικοι ανταγωνιστες του μονοπατιου hedgehog - Google Patents
Τετραϋποκατεστημενοι πυριδαζινικοι ανταγωνιστες του μονοπατιου hedgehogInfo
- Publication number
- CY1113377T1 CY1113377T1 CY20121101019T CY121101019T CY1113377T1 CY 1113377 T1 CY1113377 T1 CY 1113377T1 CY 20121101019 T CY20121101019 T CY 20121101019T CY 121101019 T CY121101019 T CY 121101019T CY 1113377 T1 CY1113377 T1 CY 1113377T1
- Authority
- CY
- Cyprus
- Prior art keywords
- trifluoromethyl
- methyl
- hydrogen
- hedgehog
- trail
- Prior art date
Links
- 241000027355 Ferocactus setispinus Species 0.000 title 1
- 239000000843 powder Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- -1 di-F-substituted cyclohexyl Chemical group 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 241000289669 Erinaceus europaeus Species 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
- 239000011737 fluorine Chemical group 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11533208P | 2008-11-17 | 2008-11-17 | |
| EP09752059A EP2358698B1 (en) | 2008-11-17 | 2009-11-05 | Tetrasubstituted pyridazine as hedgehog pathway antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1113377T1 true CY1113377T1 (el) | 2016-06-22 |
Family
ID=41722877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20121101019T CY1113377T1 (el) | 2008-11-17 | 2012-10-25 | Τετραϋποκατεστημενοι πυριδαζινικοι ανταγωνιστες του μονοπατιου hedgehog |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8507490B2 (OSRAM) |
| EP (1) | EP2358698B1 (OSRAM) |
| JP (1) | JP5518887B2 (OSRAM) |
| KR (1) | KR101342184B1 (OSRAM) |
| CN (1) | CN102216285B (OSRAM) |
| AU (1) | AU2009314349B2 (OSRAM) |
| BR (1) | BRPI0921782A2 (OSRAM) |
| CA (1) | CA2743483C (OSRAM) |
| CY (1) | CY1113377T1 (OSRAM) |
| DK (1) | DK2358698T3 (OSRAM) |
| EA (1) | EA017386B1 (OSRAM) |
| ES (1) | ES2392759T3 (OSRAM) |
| HR (1) | HRP20120762T1 (OSRAM) |
| MX (1) | MX2011005177A (OSRAM) |
| PL (1) | PL2358698T3 (OSRAM) |
| PT (1) | PT2358698E (OSRAM) |
| SI (1) | SI2358698T1 (OSRAM) |
| WO (1) | WO2010056588A1 (OSRAM) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0714872A2 (pt) * | 2006-07-17 | 2013-03-19 | Syngenta Participations Ag | derivados de piridazina |
| UA102250C2 (ru) | 2008-04-29 | 2013-06-25 | Эли Лилли Энд Компани | Двухзамещенные фталазины - антагонисты проводящего пути hedgehog |
| CN102202737B (zh) | 2008-11-03 | 2014-03-26 | 伊莱利利公司 | 二取代的2,3-二氮杂萘hedgehog通路拮抗剂 |
| KR101335770B1 (ko) | 2008-11-17 | 2013-12-12 | 일라이 릴리 앤드 캄파니 | 사치환된 피리다진 헷지호그 경로 길항제 |
| AR077014A1 (es) | 2009-06-19 | 2011-07-27 | Lilly Co Eli | Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer |
| GB201309508D0 (en) | 2013-05-28 | 2013-07-10 | Redx Pharma Ltd | Compounds |
| US9814703B2 (en) | 2013-11-14 | 2017-11-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treating cancer by activation of BMP signaling |
| GB2528298A (en) * | 2014-07-16 | 2016-01-20 | Redx Pharma Plc | Compounds |
| CN105130980B (zh) * | 2015-09-09 | 2018-05-22 | 沈阳药科大学 | N-3-苯并咪唑噻唑胺类衍生物及其制备方法与应用 |
| CN107163028B (zh) * | 2017-05-24 | 2019-07-12 | 东南大学 | 一种苯甲酰胺类Hedgehog抑制剂及其制备方法和应用 |
| CN110208424A (zh) * | 2019-06-28 | 2019-09-06 | 江苏恒生检测有限公司 | 一种农药氟啶虫酰胺中含有杂质的分析方法 |
| WO2021071981A1 (en) * | 2019-10-08 | 2021-04-15 | Skyhawk Therapeutics, Inc. | Compounds for modulating splicing |
| CN116349204A (zh) | 2020-10-13 | 2023-06-27 | 奋进生物医药公司 | 治疗纤维化的方法 |
| WO2023034836A1 (en) * | 2021-08-30 | 2023-03-09 | Remix Therapeutics Inc. | Compounds and methods for modulating splicing |
| US12447148B2 (en) | 2024-03-05 | 2025-10-21 | Endeavor Biomedicines, Inc. | Methods of improving lung function |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1293565A (en) | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
| ES2162235T3 (es) | 1996-01-15 | 2001-12-16 | Janssen Pharmaceutica Nv | Piridazinaminas inhibidoras de la angiogenesis. |
| US6432970B2 (en) | 1998-04-09 | 2002-08-13 | Johns Hopkins University School Of Medicine | Inhibitors of hedgehog signaling pathways, compositions and uses related thereto |
| WO1999052534A1 (en) | 1998-04-09 | 1999-10-21 | Johns Hopkins University School Of Medicine | Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways |
| AU780358B2 (en) | 1999-06-08 | 2005-03-17 | Lorantis Limited | Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| ATE404200T1 (de) | 2002-04-22 | 2008-08-15 | Univ Johns Hopkins Med | Modulatoren von hedgehog signalpfaden, zusammensetzungen und verwandte verwendungen |
| AU2003265853A1 (en) | 2002-08-29 | 2004-03-19 | Curis, Inc. | Hedgehog antagonists, methods and uses related thereto |
| WO2005033288A2 (en) | 2003-09-29 | 2005-04-14 | The Johns Hopkins University | Hedgehog pathway antagonists |
| TW200533356A (en) | 2004-02-24 | 2005-10-16 | Mitsubishi Pharma Corp | Fused pyridazine derivatives |
| CA2564996A1 (en) | 2004-05-08 | 2006-01-12 | Taeyoung Yoon | 3-aryl-5,6-disubstituted pyridazines |
| KR20160058972A (ko) | 2004-09-02 | 2016-05-25 | 제넨테크, 인크. | 헤지호그 신호전달에 대한 피리딜 억제제 |
| EP1900731A1 (de) | 2006-09-07 | 2008-03-19 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren |
| PE20090188A1 (es) | 2007-03-15 | 2009-03-20 | Novartis Ag | Compuestos heterociclicos como moduladores de la senda de hedgehog |
| ES2505091T3 (es) | 2007-06-25 | 2014-10-09 | Amgen Inc. | Compuestos, composiciones y métodos de uso de ftalazina |
| WO2009035568A1 (en) | 2007-09-07 | 2009-03-19 | Amgen Inc. | Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling |
| UA102250C2 (ru) | 2008-04-29 | 2013-06-25 | Эли Лилли Энд Компани | Двухзамещенные фталазины - антагонисты проводящего пути hedgehog |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
| CN102202737B (zh) | 2008-11-03 | 2014-03-26 | 伊莱利利公司 | 二取代的2,3-二氮杂萘hedgehog通路拮抗剂 |
| KR101335770B1 (ko) | 2008-11-17 | 2013-12-12 | 일라이 릴리 앤드 캄파니 | 사치환된 피리다진 헷지호그 경로 길항제 |
| AR077014A1 (es) | 2009-06-19 | 2011-07-27 | Lilly Co Eli | Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer |
-
2009
- 2009-11-05 EP EP09752059A patent/EP2358698B1/en not_active Not-in-force
- 2009-11-05 EA EA201170699A patent/EA017386B1/ru not_active IP Right Cessation
- 2009-11-05 US US13/122,216 patent/US8507490B2/en not_active Expired - Fee Related
- 2009-11-05 DK DK09752059.7T patent/DK2358698T3/da active
- 2009-11-05 PL PL09752059T patent/PL2358698T3/pl unknown
- 2009-11-05 AU AU2009314349A patent/AU2009314349B2/en not_active Ceased
- 2009-11-05 KR KR1020117011148A patent/KR101342184B1/ko not_active Expired - Fee Related
- 2009-11-05 SI SI200930351T patent/SI2358698T1/sl unknown
- 2009-11-05 ES ES09752059T patent/ES2392759T3/es active Active
- 2009-11-05 MX MX2011005177A patent/MX2011005177A/es active IP Right Grant
- 2009-11-05 WO PCT/US2009/063370 patent/WO2010056588A1/en not_active Ceased
- 2009-11-05 JP JP2011536395A patent/JP5518887B2/ja not_active Expired - Fee Related
- 2009-11-05 BR BRPI0921782A patent/BRPI0921782A2/pt not_active IP Right Cessation
- 2009-11-05 CA CA2743483A patent/CA2743483C/en not_active Expired - Fee Related
- 2009-11-05 HR HRP20120762AT patent/HRP20120762T1/hr unknown
- 2009-11-05 CN CN200980145554.8A patent/CN102216285B/zh not_active Expired - Fee Related
- 2009-11-05 PT PT09752059T patent/PT2358698E/pt unknown
-
2012
- 2012-10-25 CY CY20121101019T patent/CY1113377T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR101342184B1 (ko) | 2013-12-19 |
| CA2743483A1 (en) | 2010-05-20 |
| EP2358698A1 (en) | 2011-08-24 |
| US20110263602A1 (en) | 2011-10-27 |
| US8507490B2 (en) | 2013-08-13 |
| SI2358698T1 (sl) | 2012-11-30 |
| AU2009314349B2 (en) | 2013-04-18 |
| EA017386B1 (ru) | 2012-12-28 |
| PT2358698E (pt) | 2012-10-24 |
| DK2358698T3 (da) | 2012-10-08 |
| EP2358698B1 (en) | 2012-09-05 |
| CN102216285A (zh) | 2011-10-12 |
| JP5518887B2 (ja) | 2014-06-11 |
| CN102216285B (zh) | 2014-08-13 |
| PL2358698T3 (pl) | 2013-01-31 |
| KR20110070920A (ko) | 2011-06-24 |
| JP2012509263A (ja) | 2012-04-19 |
| ES2392759T3 (es) | 2012-12-13 |
| CA2743483C (en) | 2014-03-11 |
| WO2010056588A1 (en) | 2010-05-20 |
| BRPI0921782A2 (pt) | 2019-09-24 |
| HRP20120762T1 (hr) | 2012-10-31 |
| MX2011005177A (es) | 2011-05-30 |
| AU2009314349A1 (en) | 2010-05-20 |
| EA201170699A1 (ru) | 2011-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1113377T1 (el) | Τετραϋποκατεστημενοι πυριδαζινικοι ανταγωνιστες του μονοπατιου hedgehog | |
| CY1124187T1 (el) | Ετεροκυκλικα αμιδια ως αναστολεις κινασης | |
| CY1120864T1 (el) | Ενωσεις πυραζολης και η χρηση τους ως αναστολεις διαυλων ασβεστιου τυπου τ | |
| CY1109322T1 (el) | Παραγωγα προλινης και η χρηση τους ως αναστολεις διπεπτιδυλικης πεπτιδασης iv | |
| CY1121364T1 (el) | Νεοι κυτταροστατικοι νουκλεοζιτες 7-δεαζαπουρινης | |
| CY1120619T1 (el) | Χημικες οντοτητες | |
| CY1112754T1 (el) | Μεθοδοι και ενδιαμεσα για την παρασκευη παραγωγων ν4-φαινυλ-κιναζολιν-4-αμινης | |
| CY1111628T1 (el) | Υποκατεστημενες ενωσεις δικυκλολακταμης | |
| CY1119669T1 (el) | Παραγωγα 1-φαινυλ-2-πυριδινυλ-αλκυλ-αλκοολων ως αναστολεις φωσφοδιεστερασης | |
| CY1115227T1 (el) | Νεοι καταστολεις φωσφοδιεστερασης (phosphodiesterase) | |
| CY1113924T1 (el) | Ενωσεις καρβαζολης και θεραπευτικες χρησεις των ενωσεων | |
| CY1121804T1 (el) | Καινοτομες ενωσεις πυριμιδινης και πυριδινης και η χρηση τους | |
| CY1119534T1 (el) | Παραγωγα φωσφορου ως αναστολεις κινασης | |
| CY1117820T1 (el) | Δικυκλικες ετερο-κυκλικες ενωσεις σαν καταστολεις κινασης (kinase) πρωτεϊνης | |
| CY1115426T1 (el) | 1,3-δισυποκατεστημενα παραγωγα ιμιδαζολιδιν-2-ονης ως αναστολεις toy cyp 17 | |
| CY1117197T1 (el) | Ενωσεις τριαζολοπυριδινης ως αναστολεις της κινασης ριμ | |
| CY1110962T1 (el) | Τρικυκλικες ενωσεις και η χρηση τους ως διαμορφωτες του υποδοχεα γλυκοκορτικοειδων | |
| CY1117374T1 (el) | Παραγωγα ιμιδαζοπυριδινης, διαδικασια για την παρασκευη αυτων και θεραπευτικη χρηση αυτων | |
| CY1118362T1 (el) | Ανταγωνιστες υποδοχεων cgrp αζαϊνδανιου καρβοξαμιδιου πιπεριδινονης | |
| CY1118346T1 (el) | Αρυλoαζoλ-2-υλ κυανοαιθυλαμινο ενωσεις, μεθοδος κατασκευης και μεθοδος χρησης αυτων | |
| CY1113282T1 (el) | Αντιικα νουκλεοζιτικα αναλογα | |
| CY1121550T1 (el) | Ενωσεις πυριδινης πλαδιενολιδης και μεθοδοι χρησης | |
| CY1112311T1 (el) | Ενωσεις πυραζολινης ως ανταγωνιστες υποδοχεα αλατοκορτικοειδους | |
| CY1120355T1 (el) | Αναστολεις toy iap | |
| CY1119619T1 (el) | Παραγωγα πυριδιν-4-υλιου |